Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

Orforglipron, Eli Lilly's once-daily oral GLP-1 receptor agonist, is being studied in ongoing clinical trials for obesity and type 2 diabetes. Data shows A1C reductions...
Advances in blood glucose management, weight loss, and heart health are at the forefront of type 2 diabetes research. Here are some exciting new clinical trials you can...
Novo Nordisk is set to discontinue Levemir, a key long-acting insulin, by the end of 2024 due to manufacturing priorities and better alternatives, impacting supply and...
FDA approves Zepbound for obesity management alongside diet and exercise. A promising new option for weight control, it's the second once-weekly injectable after Wegovy...
Clinical trials are the middle step between scientific discoveries in the lab and making these discoveries available to the public. Learn how clinical trials work, the...
The T1DEXI study sheds light on the impact of exercise on type 1 diabetes, including how to manage hypoglycemia and hyperglycemia. In addition, here are some practical...
Explore the VITAL-CGM trial, which investigates if using a combination of CGM and WeightWatchers can lower A1C in people with type 2 diabetes.
Descubre las razones por las cuales los hispanos tienen un riesgo elevado de sufrir diabetes tipo 2 y encuentra consejos de expertos para prevención y manejo de la...
Halloween can be a tricky holiday to navigate. Here are some ways to make trick or treating safe for people with diabetes and some other fun activities to do that don't...
Omnipod 5 users will soon be able to control their AID system through a free iPhone app available in the new year. Like the Android app, iPhone users will be able to...
Explore the link between obesity, diabetes, and breast cancer risk. Learn how treatments like bariatric surgery and medications can reduce this risk and aid in diabetes...
Explore the benefits of Nevro's HFX spinal cord stimulation device for diabetic peripheral neuropathy. Recent studies show up to two years of pain relief and enhanced...
Learn about hearing loss prevention and management during National Protect Your Hearing Month. Explore the link between diabetes and hearing loss, signs of impairment,...
In case you missed them, here are our top stories from October 2023 that cover upcoming therapies, groundbreaking research, and more.
Evelyn Oberdorfer, 65, is a bodybuilder and half-marathon runner. She credits building her resilience from managing the highs and lows of type 1 diabetes since childhood.
While some affirm the health benefits of caffeine, like improving insulin sensitivity and blood sugar, research is mixed on whether it's detrimental for people with...
Join a study investigating BMF-219, a menin inhibitor that could stimulate healthy beta cell regeneration and potentially slow diabetes progression.
People with diabetes who are U.S. citizens or permanent residents can apply for a free lifetime America the Beautiful Pass, which offers access to over 2,000 parks,...
Medtronic unveils Simplera, the latest CGM approved in Europe for people with diabetes ages two and older. A sleek, disposable device, Simplera rivals the Dexcom G7 and...
Ongoing hostilities and violence across the world leave people with diabetes in crisis and without access to essential resources. What can be done to help?

Pages